{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:05:34Z","timestamp":1782824734376,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.forsciint.2020.110595","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T09:42:29Z","timestamp":1605346949000},"page":"110595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A comprehensive analytical process, from NPS threat identification to systematic screening: Method validation and one-year prevalence study"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2558-8598","authenticated-orcid":false,"given":"B\u00e9atrice","family":"Garneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-656X","authenticated-orcid":false,"given":"Brigitte","family":"Desharnais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Laquerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-7015","authenticated-orcid":false,"given":"Cynthia","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Taillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Daigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Mireault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lajeunesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7-8","key":"10.1016\/j.forsciint.2020.110595_bib0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/dta.319","article-title":"A brief history of \u2018new psychoactive substances\u2019","volume":"3","author":"King","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2020.110595_bib0010","series-title":"The SAGE Handbook of Drug and Alcohol Studies","article-title":"Chapter 33: what\u2019s so \"New\" about new psychoactive substances? Definitions, prevalence, motivations, user groups and a proposed new taxonomy","author":"Measham","year":"2016"},{"key":"10.1016\/j.forsciint.2020.110595_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109941","article-title":"New psychoactive substances: An actual problem or an overestimated phenomenon?","volume":"304","author":"Vaiano","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2020.110595_bib0020","series-title":"European Drug Report 2019","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0025","series-title":"World Drug Report 2019. Austria","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0030","volume":"Volume II","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0035","series-title":"American Academy of Forensic Sciences 71st Annual Meeting","article-title":"Retrospective data-mining of toxicology data as a tool for NPS identification","author":"Papsun","year":"2019"},{"issue":"1","key":"10.1016\/j.forsciint.2020.110595_bib0040","first-page":"86","article-title":"Challenges related to three cases of fatal intoxication to multiple novel synthetic opioids","volume":"44","author":"Garneau","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110595_bib0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.forsciint.2019.02.021","article-title":"Death cases involving certain new psychoactive substances: a review of the literature","volume":"298","author":"Kraemer","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2020.110595_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109892","article-title":"Fatalities related to new psychoactive substances in Singapore\u2014a case series","volume":"304","author":"Chan","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2020.110595_bib0055","article-title":"Driving impairment cases involving etizolam and flubromazolam","author":"Rohrig","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110595_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases","author":"Heide","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110595_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.02.040","article-title":"A fatal case of poisoning of a 19-year-old after taking 3-MMC","volume":"300","author":"Margasi\u0144ska-Olejak","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.forsciint.2020.110595_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bky049","article-title":"The opioid epidemic: moving toward an integrated, holistic analytical response","volume":"43","author":"Morrow","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110595_bib0075","volume":"Volume I","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2019"},{"issue":"8","key":"10.1016\/j.forsciint.2020.110595_bib0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jat\/bky054","article-title":"Quantitative analysis of fentanyl and six fentanyl analogs in postmortem specimens by UHPLC-MS-MS","volume":"42","author":"Kahl","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"9","key":"10.1016\/j.forsciint.2020.110595_bib0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jat\/bky035","article-title":"Analysis of fentanyl and 18 novel fentanyl analogs and metabolites by LC-MS-MS, and report of fatalities associated with Methoxyacetylfentanyl and cyclopropylfentanyl","volume":"42","author":"Fogarty","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.forsciint.2020.110595_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jat\/bky087","article-title":"Development and validation of a novel all-inclusive LC\u2013MS-MS designer drug method","volume":"43","author":"Strickland","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2020.110595_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpba.2018.10.011","article-title":"Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices","volume":"163","author":"Graziano","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2020.110595_bib0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpba.2016.07.009","article-title":"A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS\/MS and application to real cases","volume":"129","author":"Vaiano","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2020.110595_bib0105","series-title":"2017 Society of Forensic Toxicologists Meeting (SOFT) and 55th Annual Meeting of the International Association of Forensic Toxicologists (TIAFT)","article-title":"High throughput protein precipitation: screening and quantification of 106 drugs and their metabolites using LC-MS\/MS","author":"C\u00f4t\u00e9","year":"2017"},{"key":"10.1016\/j.forsciint.2020.110595_bib0110","series-title":"ISO\/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories","author":"ISO\/IECInternational Organization for Standardization (ISO)","year":"2017"},{"key":"10.1016\/j.forsciint.2020.110595_bib0115","series-title":"Guideline on Bioanalytical Method Validation","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2009"},{"key":"10.1016\/j.forsciint.2020.110595_bib0120","series-title":"Standard Practices for Method Validation in Forensic Toxicology Colorado, USA","author":"Toxicology Consensus Body, Academy Standards Board (ASB)","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0125","series-title":"Food and Drug Administation (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM)","author":"U.S Department of Health and Human Services","year":"2018"},{"issue":"9","key":"10.1016\/j.forsciint.2020.110595_bib0130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/dta.2867","article-title":"Qualitative threshold method validation and uncertainty evaluation: a theoretical framework and application to a 40 analytes LC-MS\/MS method","volume":"12","author":"Camirand Lemyre","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2020.110595_bib0135","series-title":"Tri-Council Policy Statement - Ethical Conduct for Research Involving Humans","author":"Canadian Institute of Health Research (CIHR)","year":"2018"},{"key":"10.1016\/j.forsciint.2020.110595_bib0140","unstructured":"SWGDRUG Mass Spectral Library In. Scientific Working Group for the Analysis of Seized Dugs (SWGDRUG). 2020. http:\/\/www.swgdrug.org\/ms.htm. Accessed May 29th, 2020."},{"key":"10.1016\/j.forsciint.2020.110595_bib0145","series-title":"Cayman Chemical","author":"Cayman Spectral Library In","year":"2020"},{"key":"10.1016\/j.forsciint.2020.110595_bib0150","series-title":"Appel \u00e0 la vigilance: Cas de surdoses s\u00e9v\u00e8res li\u00e9s \u00e0 l\u2019ingestion de flubromazolam vendu comme du Xanax","author":"Lampron-Goulet","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0155","series-title":"Public Health Alert","article-title":"Potent synthetic opioid \u2013 isotonitazene \u2013 recently identified in the midwestern United States","author":"Krotulski","year":"2019"},{"issue":"4","key":"10.1016\/j.forsciint.2020.110595_bib0160","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/add.14868","article-title":"New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017","volume":"115","author":"Hondebrink","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2020.110595_bib0165","series-title":"57th Annual Meeting of the International Association of Forensic Toxicologists (TIAFT)","article-title":"When cultural differences breed a separate toxicological ecosystem: the province of Qu\u00e9bec (Canada) and the opioids crisis","author":"Garneau","year":"2019"},{"key":"10.1016\/j.forsciint.2020.110595_bib0170","series-title":"Opioid-related harms in Canada","author":"Special Advisory Committee on the Epidemic of Opioid Overdoses","year":"2020"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073820304576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073820304576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:03:28Z","timestamp":1759946608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073820304576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"alternative-id":["S0379073820304576"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2020.110595","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive analytical process, from NPS threat identification to systematic screening: Method validation and one-year prevalence study","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2020.110595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110595"}}